Levosimendan: use, cost-effectiveness and outcome in a tertiary cardiothoracic centre

Similar Items

• Extracorporeal membrane oxygenator (ECMO) and ventricular assist device (VAD) activity of a tertiary cardiothoracic centre: survival rates and length of ITU stay
  od: Sarridou, D, i dr.
  Izdano: (2015)
• Outcomes following repatriation from cardiothoracic intensive care to referring centres
  od: Abu Al-Saad, N, i dr.
  Izdano: (2015)
• Critical care outreach: implementation in a cardiothoracic centre
  od: Carbery, C, i dr.
  Izdano: (2005)
• Introduction of weekly multidisciplinary teammeetings in a tertiary cardiothoracic critical care unit: evaluation of staff satisfaction and impact on clinical outcomes
  od: Gelvez-Zapata, S, i dr.
  Izdano: (2015)
• Outcome of haematology patients admitted to intensive care in a tertiary centre: primary haematological diagnosis, recent chemotherapy and bone marrow transplantation are not associated with outcome
  od: José, R, i dr.
  Izdano: (2011)